/compare — side-by-sideLOADING
Valuation, growth, margins and forensic scores side-by-side — computed from each company's own SEC filings and last EOD close. No estimates, no fluff.
| Metric | NDRAENDRA Life Sciences |
|---|---|
| Last close | $4.73close 2026-11-06 |
| Change % | -5.49%close 2026-11-06 |
| Market cap | $7Mclose 2026-11-06 |
| P/E | loss, no P/E |
| Revenue | $0⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldRevenues As ofFY ending 2020-12-31 Filing10-K · 0001654954-21-003302 · filed 2021-03-25 Open the filing on EDGAR →Open the XBRL payload → |
Fundamentals from XBRL company facts (as filed); market cap & P/E use last EOD close. Each cell names its period. A ratio row reads not comparable when the companies’ periods differ by more than six weeks or mix a fiscal year with a trailing twelve months, and a figure more than a year older than the company’s newest period is marked older period. No row ranks the companies. Educational only, not investment advice.
| Rev growth (YoY) | no prior year filed |
| Net income | $-7027410⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldNetIncomeLoss As ofFY ending 2025-12-31 FilingS-4 · 0001193125-26-410883 · filed 2026-10-02 Open the filing on EDGAR →Open the XBRL payload →CiteENDRA Life Sciences Inc. (NDRA), us-gaap:NetIncomeLoss: -7,027,410 USD, fiscal year ended 2025-12-31. Form S-4, accession 0001193125-26-410883, filed 2026-10-02. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001681682/us-gaap/NetIncomeLoss.json |
| Net margin | periods differ |
| EPS (diluted) | $-8.93⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldEarningsPerShareDiluted As ofFY ending 2025-12-31 FilingS-4 · 0001193125-26-410883 · filed 2026-10-02 Open the filing on EDGAR →Open the XBRL payload →CiteENDRA Life Sciences Inc. (NDRA), us-gaap:EarningsPerShareDiluted: -8.93 USD per share, fiscal year ended 2025-12-31. Form S-4, accession 0001193125-26-410883, filed 2026-10-02. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001681682/us-gaap/EarningsPerShareDiluted.json |
| Piotroski F-ScoreUNVALIDATED | 3FY to 2020-12-31, older period |
| Altman Z-ScoreUNVALIDATED | -9.83FY to 2020-12-31, older period |
| Beneish M-ScoreUNVALIDATED | inputs not filed |
| Next earnings | 03-25 → 04-04 |